ArticleBMC infectious diseases2026
Reevaluating late HIV diagnosis incorporating recent infection evidence: a population-based study in Southwest China (2020-2023).
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundDespite global advances in HIV treatment and prevention, the proportion of patients with late HIV diagnosis remains persistently high. The CD4-based definition of late HIV diagnosis has limitations during early seroconversion when the CD4 count may transiently decrease, leading to misclassification and overestimation. This study integrated evidence of recent infection from HIV testing history to redefine late HIV diagnosis, quantify the extent of overestimation, and identify factors associated with reclassification.
methodsWe conducted a population-based study on newly reported people living with HIV from 2020 to 2023 in a prefecture-level city in Southwest China. Data were obtained from the Comprehensive Response Information Management System and matched with the Universal Health Information System. People initially classified as late (CD4 count < 350 cells/µL or an AIDS-defining event) were reclassified as non-late if they had a documented negative HIV test within 12 months before diagnosis. The proportion of patients with a late HIV diagnosis was recalculated after reclassification. Multivariate logistic regression was used to identify factors associated with reclassification.
resultsAmong 5,481 newly reported people living with HIV, 2,228 (40.65%) had a documented previous negative HIV test. After reclassification, the proportion of patients with late HIV diagnosis decreased from 62.89% (3,447/5,481) to 53.68% (2,942/5,481). Older individuals presented a higher correction rate (19.56%). Among the subgroup of people with a previous negative HIV testing history, the proportion decreased from 61.62% (1,373/2,228) to 38.96% (868/2,228). Multivariable analysis revealed that, compared to individuals aged < 50 years, those aged ≥ 60 years were significantly more likely to be reclassified (aOR: 1.426, 95% CI: 1.008-2.017).
conclusionsRelying solely on the CD4-based definition overestimates the prevalence of late HIV diagnosis, particularly among older adults. Incorporating evidence of recent infection into the definition can improve the accuracy of late HIV diagnosis assessments. However, individuals presenting with low CD4 count during recent infection remain highly vulnerable and require immediate antiretroviral therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.